Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luca Richeldi

Showing results (291-300 of 356) with videos related to

Pageof 36
Sort By:
American Journal of Respiratory and Critical Care Medicine|January 2, 2025
Impact of Environmental Exposures on the Development and Progression of Fibrotic Interstitial Lung DiseaseKerri A Johannson, Ayodeji Adegunsoye, Jürgen Behr, et al.
American Journal of Respiratory and Critical Care Medicine|April 15, 2022
Reticulation Is a Risk Factor of Progressive Subpleural Nonfibrotic Interstitial Lung AbnormalitiesYuchen Zhang, Huajing Wan, Luca Richeldi, et al.
ERJ Open Research|September 24, 2025
Online home spirometry in national pulmonary fibrosis care: insights from daily practiceGizal Nakshbandi, Catharina C Moor, Tonia Magrì, et al.
Annals of the American Thoracic Society|September 13, 2023
Approach to Clinical Trials for the Prevention of Pulmonary FibrosisJohn S Kim, Sydney B Montesi, Ayodeji Adegunsoye, et al.
The American Journal of the Medical Sciences|April 24, 2019
The Fibrosis Across Organs Symposium: A Roadmap for Future Research PrioritiesJesse Roman, Teresa R Barnes, Dolly J Kervitsky, et al.
ERJ Open Research|October 27, 2018
Safety and tolerability of nintedanib for the treatment of idiopathic pulmonary fibrosis in routine UK clinical practiceSophie V Fletcher, Mark G Jones, Elizabeth A Renzoni, et al.
The New England Journal of Medicine|October 1, 2019
Nintedanib in Progressive Fibrosing Interstitial Lung DiseasesKevin R Flaherty, Athol U Wells, Vincent Cottin, et al.
Multidisciplinary Respiratory Medicine|August 5, 2025
Perception of the role of Telemedicine in Interstitial Lung Diseases: -Findings from Società Italiana di Pneumologia/ Italian Respiratory -Society (SIP-IRS) surveyGiorgio Monteleone, Gioele Castelli, Giovanni Franco, et al.
The Journal of Biological Chemistry|August 21, 2021
Bidirectional epithelial-mesenchymal crosstalk provides self-sustaining profibrotic signals in pulmonary fibrosisLiudi Yao, Yilu Zhou, Juanjuan Li, et al.
Lung|July 8, 2025
Effectiveness of Nintedanib in Progressive Pulmonary Fibrosis Assessed by Progression Criteria: An Italian, Observational, Multicenter StudyMichele Mondoni, Francesco Varone, Fabrizio Luppi, et al.
Pageof 36

Showing results (291-300 of 356) with videos related to

Sort By:
Pageof 36
American Journal of Respiratory and Critical Care Medicine|January 2, 2025
Impact of Environmental Exposures on the Development and Progression of Fibrotic Interstitial Lung DiseaseKerri A Johannson, Ayodeji Adegunsoye, Jürgen Behr, et al.
American Journal of Respiratory and Critical Care Medicine|April 15, 2022
Reticulation Is a Risk Factor of Progressive Subpleural Nonfibrotic Interstitial Lung AbnormalitiesYuchen Zhang, Huajing Wan, Luca Richeldi, et al.
ERJ Open Research|September 24, 2025
Online home spirometry in national pulmonary fibrosis care: insights from daily practiceGizal Nakshbandi, Catharina C Moor, Tonia Magrì, et al.
Annals of the American Thoracic Society|September 13, 2023
Approach to Clinical Trials for the Prevention of Pulmonary FibrosisJohn S Kim, Sydney B Montesi, Ayodeji Adegunsoye, et al.
The American Journal of the Medical Sciences|April 24, 2019
The Fibrosis Across Organs Symposium: A Roadmap for Future Research PrioritiesJesse Roman, Teresa R Barnes, Dolly J Kervitsky, et al.
ERJ Open Research|October 27, 2018
Safety and tolerability of nintedanib for the treatment of idiopathic pulmonary fibrosis in routine UK clinical practiceSophie V Fletcher, Mark G Jones, Elizabeth A Renzoni, et al.
The New England Journal of Medicine|October 1, 2019
Nintedanib in Progressive Fibrosing Interstitial Lung DiseasesKevin R Flaherty, Athol U Wells, Vincent Cottin, et al.
Multidisciplinary Respiratory Medicine|August 5, 2025
Perception of the role of Telemedicine in Interstitial Lung Diseases: -Findings from Società Italiana di Pneumologia/ Italian Respiratory -Society (SIP-IRS) surveyGiorgio Monteleone, Gioele Castelli, Giovanni Franco, et al.
The Journal of Biological Chemistry|August 21, 2021
Bidirectional epithelial-mesenchymal crosstalk provides self-sustaining profibrotic signals in pulmonary fibrosisLiudi Yao, Yilu Zhou, Juanjuan Li, et al.
Lung|July 8, 2025
Effectiveness of Nintedanib in Progressive Pulmonary Fibrosis Assessed by Progression Criteria: An Italian, Observational, Multicenter StudyMichele Mondoni, Francesco Varone, Fabrizio Luppi, et al.
Pageof 36